Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
California Institute for Biomedical Research
Headquarters: La Jolla, CA, United States of America
Website: http://www.calibr.org
Year Founded: 2012
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Feb 10, 2021
Deals
CRISPR play Caribou broadens therapeutics reach with AbbVie deal to develop allogeneic CAR Ts
After giving up rights to CRISPR-Cas9 for most therapeutic applications years ago, Jennifer Doudna-founded Caribou is now teaming up with AbbVie to use a different CRISPR enzyme to create allogeneic
BioCentury | Aug 23, 2019
Clinical News
Aug. 22 Clinical Quick Takes: Rituximab biosimilar meets endpoint; plus Aimmune, NKMax, Calibr
BioCentury | Jul 25, 2019
Distillery Therapeutics
A tumor-targeted Bavencio conjugate with enhanced antitumor efficacy
BioCentury | Mar 22, 2019
Targets & Mechanisms
Deconvoluting translation at Scripps
Why Scripps Research's non-profit model is doubling down on target discovery
BioCentury | Mar 19, 2019
Distillery Therapeutics
New brain-penetrating RIPK2 inhibitor prodrug for GBM
BioCentury | Mar 22, 2018
Translation in Brief
Mining marine metabolites
Sirenas, BMS use AI to discover small molecule microbiome metabolites
Items per page:
1 - 10 of 36